These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 10449599

  • 21. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.
    Vaziri SA, Krumroy LM, Rostai M, Casey G.
    Hum Mutat; 2001; 17(1):74. PubMed ID: 11139249
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [Abstract] [Full Text] [Related]

  • 24. Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer.
    Santarosa M, Viel A, Dolcetti R, Crivellari D, Magri MD, Pizzichetta MA, Tibiletti MG, Gallo A, Tumolo S, Del Tin L, Boiocchi M.
    Int J Cancer; 1998 Nov 23; 78(5):581-6. PubMed ID: 9808526
    [Abstract] [Full Text] [Related]

  • 25. Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.
    Coppa A, Buffone A, Capalbo C, Nicolussi A, D'Inzeo S, Belardinilli F, Colicchia V, Petroni M, Granato T, Midulla C, Zani M, Ferraro S, Screpanti I, Gulino A, Giannini G.
    Breast Cancer Res Treat; 2014 Dec 23; 148(3):629-35. PubMed ID: 25395318
    [Abstract] [Full Text] [Related]

  • 26. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
    Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.
    Gynecol Oncol; 2000 Sep 23; 78(3 Pt 1):278-87. PubMed ID: 10985881
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D, Bremer M, Rades D, Skawran B, Siebrands C, Karstens JH, Dörk T.
    Br J Cancer; 2001 Sep 14; 85(6):850-8. PubMed ID: 11556836
    [Abstract] [Full Text] [Related]

  • 29. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.
    Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA.
    Cancer; 2000 Mar 15; 88(6):1393-402. PubMed ID: 10717622
    [Abstract] [Full Text] [Related]

  • 30. BRCA1 and BRCA2 mutations in central and southern Italian patients.
    Ottini L, D'Amico C, Noviello C, Lauro S, Lalle M, Fornarini G, Colantuoni OA, Pizzi C, Cortesi E, Carlini S, Guadagni F, Bianco AR, Frati L, Contegiacomo A, Mariani-Costantini R.
    Breast Cancer Res; 2000 Mar 15; 2(4):307-10. PubMed ID: 11056688
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.
    Lancaster JM, Carney ME, Gray J, Myring J, Gumbs C, Sampson J, Wheeler D, France E, Wiseman R, Harper P, Futreal PA.
    Br J Cancer; 1998 Dec 15; 78(11):1417-20. PubMed ID: 9836472
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G, Capalbo C, Ristori E, Ricevuto E, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A.
    Breast Cancer Res Treat; 2006 Nov 15; 100(1):83-91. PubMed ID: 16847550
    [Abstract] [Full Text] [Related]

  • 38. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
    Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL.
    Am J Hum Genet; 2000 Oct 15; 67(4):841-50. PubMed ID: 10978226
    [Abstract] [Full Text] [Related]

  • 39. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P, Zikan M, Stribrna J, Kleibl Z, Janatova M, Kotlas J, Zidovska J, Novotny J, Petruzelka L, Szabo C, Matous B.
    Breast Cancer Res; 2005 Oct 15; 7(5):R728-36. PubMed ID: 16168118
    [Abstract] [Full Text] [Related]

  • 40. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
    Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G.
    Ann Oncol; 2006 Jun 15; 17 Suppl 7():vii34-40. PubMed ID: 16760289
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.